Amit Nathubhai

Amit Nathubhai

Auto-generated profile, based on publicly available information

Amit Nathubhai

Molecular Bioscience Research Group, Centre for Physical Activity and Life Sciences University of Northampton UK

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ANAmit Nathubhai
Amit Nathubhai
THTeemu Haikarainen
Teemu Haikarainen
JKJarkko Koivunen
Jarkko Koivunen
SMSudarshan Murthy
Sudarshan Murthy
FKFrancoise Koumanov
Francoise Koumanov
MTMichael D. Threadgill
Michael D. Threadgill

1 September 2015 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Open access
HPHelen A. Paine
Helen A. Paine
ANAmit Nathubhai
Amit Nathubhai
EWEsther Woon
Esther Woon
PSPeter T. Sunderland
Peter T. Sunderland
PWPauline J. Wood
Pauline J. Wood
MTMichael D. Threadgill
Michael D. Threadgill
Tankyrases-1 and -2 (TNKS-1 and TNKS-2) have three cellular roles which make them important targets in cancer. Using NAD(+) as a substrate, they poly(ADP-ribosyl)ate TRF1 (regulating lengths of telomeres), NuMA (facilitating mitosis) and axin (in wnt/β-catenin signalling). Using molecular modelling and the structure of the weak inhibitor 5-aminoiso quinolin-1-one, 3-aryl-5-substituted-isoquinolin-1-ones were designed as inhibitors to explore the structure-activity relationships (SARs) for binding and to define the shape of a hydrophobic cavity in the active site. 5-Amino-3-arylisoquinolinones were synthesised by Suzuki-Miyaura coupling of arylboronic acids to 3-bromo-1-methoxy-5-nitro-isoquinoline, reduction and O-demethylation. 3-Aryl-5-methylisoquinolin-1-ones, 3-aryl-5-fluoroisoquinolin-1-ones and 3-aryl-5-methoxyisoquinolin-1-ones were accessed by deprotonation of 3-substituted-N,N,2-trimethylbenzamides and quench with an appropriate benzonitrile. SAR around the isoquinolinone core showed that aryl was required at the 3-position, optimally with a para-substituent. Small meta-substituents were tolerated but groups in the ortho-positions reduced or abolished activity. This was not due to lack of coplanarity of the rings, as shown by the potency of 4,5-dimethyl-3-phenylisoquinolin-1-one. Methyl and methoxy were optimal at the 5-position. SAR was rationalised by modelling and by crystal structures of examples with TNKS-2. The 3-aryl unit was located in a large hydrophobic cavity and the para-substituents projected into a tunnel leading to the exterior. Potency against TNKS-1 paralleled potency against TNKS-2. Most inhibitors were highly selective for TNKSs over PARP-1 and PARP-2. A range of highly potent and selective inhibitors is now available for cellular studies.

1 May 2026 in FEBS Open Bio
Verified
Journal Article
Open access
DYDavid A. Young
David A. Young
OAOmar Arias‐Gaguancela
Omar Arias‐Gaguancela
FGFiona Gibson
Fiona Gibson
MGMorgan Grainger
Morgan Grainger
JSJodie Score
Jodie Score
Lee MachadoLee Machado
Lee Machado
FcγRI is a high‐affinity receptor for IgG, associated with autoimmune disease pathology and determines clinical responses to antibody‐based immunotherapies. FcγRI has a complex evolutionary history that is not fully understood, and to address this we explored signatures of positive selection in the receptor's functional gene, FCGR1A, using codon‐based selection tests on aligned 1–1 orthologous sequences from placental mammals ( n = 32). Signatures of positive selection have occurred at several locations within the gene, with two sites (H 148 (M2a ω 0.997 & M8 ω = 0.993)) and (W 149 (M2a ω = 0.999 & M8 ω = 1.000)) exhibiting highest posterior probabilities, suggesting strong evidence of positive selection; these positions are known to form one of the FcγRI‐IgG binding interfaces. We employed ancestral reconstruction to statistically infer prior codon sequences at these sites and identified ancestral H 148 P and W 149 R codons at different nodes in the phylogeny. Employing molecular dynamics simulations, we determined how evolutionary changes at these sites may have influenced the binding of FcγRI‐IgG of modern‐day Homo sapiens . Measuring RMSD, free energy, radius of gyration, hydrogen bond formation, and analyzing free energy landscapes, we demonstrate that structural instability between mutant structures vs the WT counterpart; however, overall binding potential increases at position 148, yet decreases at 149 in potential. H 148 P protonation at physiological pH remains similar, yet during acidotic calculations, protonation is likely reduced, with predicted reduction in affinity for IgG. While ancestral W 149 R substitutions demonstrate an implication for electron conjugation. Examining key sites at this binding FcγRI‐IgG interface, our data demonstrate that these two codons have evolved in humans to be relatively insensitive to shifts in pH promoting a more stable interaction with the Fc portion of IgG during diseases that promote acidosis.